ArticleJournal for immunotherapy of cancer2024

Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.

Jiemiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.